Compounds > dipyridamole

dipyridamole and tirofiban

dipyridamole has been researched along with tirofiban in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Mohammad, SF; Solen, KA; Sukavaneshvar, S1
Ito, H; Kimura, Y; Ozeki, Y; Sudo, T1
Azevedo, R; Beierlein, W; Dietz, K; Straub, A; Wendel, HP; Ziemer, G1
Fontana, P1

Reviews

2 review(s) available for dipyridamole and tirofiban

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
[Update on antithrombotic treatments in arterial diseases].
    Revue medicale suisse, 2007, Feb-07, Volume: 3, Issue:97

    Topics: Abciximab; Antibodies, Monoclonal; Anticoagulants; Arteriosclerosis; Aspirin; Dipyridamole; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Pyridines; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine

2007

Other Studies

4 other study(ies) available for dipyridamole and tirofiban

ArticleYear
An in-vitro model to study device-induced thrombosis and embolism: evaluation of the efficacy of tirofiban, aspirin, and dipyridamole.
    Thrombosis and haemostasis, 2000, Volume: 83, Issue:2

    Topics: Animals; Anticoagulants; Aspirin; Blood Flow Velocity; Cattle; Dipyridamole; Dose-Response Relationship, Drug; Edetic Acid; Embolism; Equipment and Supplies; Equipment Design; Evaluation Studies as Topic; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Scattering, Radiation; Stents; Thrombosis; Tirofiban; Tyrosine

2000
[New antiplatelet agents].
    Investigacion clinica, 2000, Volume: 41, Issue:3

    Topics: Abciximab; Acetates; Antibodies, Monoclonal; Anticoagulants; Aspirin; Clopidogrel; Cyclooxygenase Inhibitors; Dipyridamole; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors; Ticlopidine; Tirofiban; Tyrosine

2000
Estimation of anti-platelet drugs on human platelet aggregation with a novel whole blood aggregometer by a screen filtration pressure method.
    British journal of pharmacology, 2001, Volume: 133, Issue:8

    Topics: Adenosine Diphosphate; Amino Acid Chloromethyl Ketones; Aspirin; Blood Coagulation; Blood Platelets; Cilostazol; Collagen; Dipyridamole; Filtration; Heparin; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Function Tests; Pressure; Tetrazoles; Time Factors; Tirofiban; Tyrosine

2001
Tirofiban (Aggrastat) protects platelets and decreases platelet-granulocyte binding in an extracorporeal circulation model.
    The Thoracic and cardiovascular surgeon, 2006, Volume: 54, Issue:3

    Topics: Aprotinin; Binding, Competitive; Biomarkers; Blood Platelets; Dipyridamole; Eptifibatide; Extracorporeal Circulation; Flow Cytometry; Granulocytes; Humans; Male; Milrinone; P-Selectin; Peptides; Phosphodiesterase Inhibitors; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Serine Proteinase Inhibitors; Tirofiban; Tyrosine

2006